No Improvement of Survival for Alveolar Rhabdomyosarcoma Patients After HLA-Matched Versus -Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Compared to Standard-of-Care Therapy

Benutzer: Gast

Dokumenttyp:: Zeitschriftenaufsatz
Autor(en):: Schober, Sebastian Johannes ; Hallmen, Erika ; Reßle, Florian ; Gassmann, Hendrik ; Prexler, Carolin ; Wawer, Angela ; von Luettichau, Irene ; Ladenstein, Ruth ; Kazanowska, Bernarda ; Ljungman, Gustaf ; Niggli, Felix ; Lohi, Olli ; Hauer, Julia ; Gruhn, Bernd ; Klingebiel, Thomas ; Bader, Peter ; Burdach, Stefan ; Lang, Peter ; Sparber-Sauer, Monika ; Koscielniak, Ewa ; Thiel, Uwe
Titel:: No Improvement of Survival for Alveolar Rhabdomyosarcoma Patients After HLA-Matched Versus -Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Compared to Standard-of-Care Therapy
Stichworte:: Oncology ; allogeneic stem cell transplantation ; haploidentical ; high-risk rhabdomyosarcoma ; alveolar rhabdomyosarcoma (RMA) stage IV ; matched-pair analysis ; graft-versus-host disease ; transplant-related mortality
Zeitschriftentitel:: Frontiers in Oncology
Jahr:: 2022
Band / Volume:: 12
Volltext / DOI:: doi:10.3389/fonc.2022.878367
Verlag / Institution:: Frontiers Media S.A.
E-ISSN:: 2234-943X
Publikationsdatum:: 10.05.2022
CC-Lizenz:: by, https://creativecommons.org/licenses/by/4.0

BibTeX

Vorkommen: